Low grade of satisfaction related to the use of current systemic therapies among pustular psoriasis patients: a therapeutic unmet need to be fulfilledGiulia Coscarella, Ketty Peris, Gennaro Marco Falco et al.|Frontiers in Medicine|2024Cited by 3
Residual disease is the main, but not the only factor impacting satisfaction in psoriatic patients undergoing biological therapiesGiacomo Caldarola, Clara De Simone, Ketty Peris et al.|International Journal of Dermatology|2024Cited by 3
Superior Clinical and Economic Value of <scp>IL</scp> ‐23 Inhibitors Versus Adalimumab Biosimilars in Plaque PsoriasisGennaro Marco Falco, Ketty Peris, Lucia Di Nardo et al.|International Journal of Dermatology|2026Cited by 1